Abschluss eines nicht-exklusiven Rabattvertrags nach § 130a Abs. 8 SGB V zu dem Wirkstoff Agomelatin, ATC-Code: N06AX22, für die Zeit vom 1.4.2019 bis zum 31.3.2021

World Biggest Tenders Source

This tender with title Abschluss eines nicht-exklusiven Rabattvertrags nach § 130a Abs. 8 SGB V zu dem Wirkstoff Agomelatin, ATC-Code: N06AX22, für die Zeit vom 1.4.2019 bis zum 31.3.2021 has been published on Bidding Source portal dated 04 Mar 2019 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Tender Title :

Abschluss eines nicht-exklusiven Rabattvertrags nach § 130a Abs. 8 SGB V zu dem Wirkstoff Agomelatin, ATC-Code: N06AX22, für die Zeit vom 1.4.2019 bis zum 31.3.2021

Tender Type :

Contract notice

Reference No. :

2019/S 043-097384

Country :

Germany

Province/City :

Germany-Aachen

Publish Date :

4 Mar 2019

Closing Date :

5 Feb 2021

Notice Language :

English

Tender Categories (CPVs) :

Pharmaceutical products

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

693034- Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-31 - Denosumab Germany 692194- Germany – Pharmaceutical products – Drug discount agreements with accession option Germany 692978- Germany – Pharmaceutical products – Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a, Paragraph 8 of the German Social Code (SGB V) through an open-house model for the active ingredient golimumab (ATC code according to WHO: L04AB06) Germany 692300-Awarded - Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V between IKK classic and Novartis Pharma GmbH for Kesimpta Germany 678563- Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-28 - Abatacept Germany 680694- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a, Paragraph 8 of the Social Code Book V for medicinal products (open-house procedure) Germany 679895- Germany – Pharmaceutical products – Pharmaceutical discount agreements from 01.12.2025 for various active ingredients within the framework of an open-house procedure Germany 682722- Germany – Pharmaceutical products – Open house drug discount agreements for the active ingredient Rotigotine, ATC N04BC09 Germany 682674- Germany – Pharmaceutical products – Open house drug discount agreements for the active ingredient diltiazem, ATC C08DB01 Germany 681628- Germany – Pharmaceutical products – Open house drug discount agreements for the active ingredients formoterol and beclometasone, ATC R03AK08 Germany

Abschluss eines nicht-exklusiven Rabattvertrags nach § 130a Abs. 8 SGB V zu dem Wirkstoff Agomelatin, ATC-Code: N06AX22, für die Zeit vom 1.4.2019 bis zum 31.3.2021

General Information

Germany

Similar Tenders

Pharmaceutical products Tenders

Germany Tenders

Europe Tenders

Tenders

info@biddingsource.com